ArticleJournal of comparative effectiveness researchPublished
Healthcare cost comparison between first-line ibrutinib and acalabrutinib in chronic lymphocytic leukemia patients in the Veterans Affairs
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of comparative effectiveness research
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Benzamides; Piperidines; Pyrazines; Adenine; Protein Kinase Inhibitors; Retrospective Studies; United States Department of Veterans Affairs; Aged; Aged, 80 and over; Middle Aged; Health Care Costs
- PubMed ID
- 41084890
- PubMed Central ID
- PMC12580920
- Open access
- Yes, open
- Added to directory
- Source checked